Abeona Therapeutics competitors

Abeona Therapeutics Competitors include GenVec, miRagen Therapeutics, Solid BioSciences and Exonics Therapeutics.
Add company...
Abeona Therapeutics
Abeona Therapeutics
Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome.
GenVec
GenVec
GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.
miRagen Therapeutics
miRagen Therapeutics
miRagen Therapeutics is focused on developing therapeutics for the treatment of cardiovascular and muscle diseases.
Solid BioSciences
Solid BioSciences
Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy.
Exonics Therapeutics
Exonics Therapeutics
Exonics Therapeutics develops gene editing technologies to permanently correct the majority of duchenne muscular dystrophy mutations.
Founding Date
Founding Date
2013
Founding Date
1992
Founding Date
2007
Founding Date
2013
Founding Date
2017
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Dallas, US HQ
Locations
Gaithersburg, US HQ
Locations
Boulder, US HQ
Locations
Cambridge, US HQ
Greater London, GB
Greater London, GB
New York, US
Locations
Cambridge, US HQ
Dallas, US
Employees
Employees
19217% increase
Employees
N/A
Employees
51
Employees
603% decrease
Employees
N/A
Valuation ($)
Valuation ($)
353.1 m
Valuation ($)
N/A
Valuation ($)
91.3 m
Valuation ($)
830.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
709
Twitter followers
268
Twitter followers
395
Twitter followers
225
Twitter followers
96

Financial

Revenue (est.)
Revenue (est.)
$837k (FY, 2017)
Revenue (est.)
$511k (FY, 2016)
Revenue (est.)
$4m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($27.3m) (FY, 2017)
Net income
($5.8m) (FY, 2016)
Net income
($26.5m) (FY, 2017)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 128.7m
Total funding raised
$ 2m
Total funding raised
N/A
Total funding raised
$ 92.5m
Total funding raised
$ 45m
For sources of this data, please see the company profileDownload Excel

View company profiles

GenVec
HQ
Gaithersburg, US

GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.

View company
miRagen Therapeutics
HQ
Boulder, US
Employees
51

miRagen Therapeutics is focused on developing therapeutics for the treatment of cardiovascular and muscle diseases.

View company
Solid BioSciences
HQ
Cambridge, US
Employees
60↓ 3% decrease

Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy.

View company
Exonics Therapeutics
HQ
Cambridge, US

Exonics Therapeutics develops gene editing technologies to permanently correct the majority of duchenne muscular dystrophy mutations.

View company